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The potential application of a hydrogel-based strong anion-exchange (Q) membrane to purify 
plasmid DNAs was evaluated. The maximum binding capacity of plasmid DNA was 
estimated to be 12.4 mg/ml of membrane volume with a plasmid DNA recovery of ~ 90%, 
which is superior to other commercially available anion-exchange resins and membranes. 
The membrane was able to retain its structural integrity and performance after multiple 
cycles of usage (> 30 cycles). The inherent properties of plasmid DNA, membrane adsorbent, 
and the ionic environment on membrane performance were identified as the factors affecting 
membrane performance and their effects were systematically investigated. Plasmid DNAs 
with smaller tertiary structure have shorter dynamic radius and/or lowersurface charge 
densities, which tended to have a better adsorption and recovery than those with larger 
tertiary structure. Environmental Scanning Electron Microscopy (ESEM) revealed that the 
hydrogel structure is more porous on one side of membrane than the other, and higher 
plasmid DNA adsorption and recovery capacities were observed if the more porous side of 
the membrane was installed upward of flow in the chromatographic unit. ESEM also 
revealed improved pore distribution and increased membrane porosity if membrane was pre-
equilibrated in the buffer solution for 16 hours.  The development of better flow through 
channel in the hydrogel membrane upon extensive soaking further improved plasmid DNA 
adsorption and recovery capacities. The ionic environment affects the tertiary size of plasmid 
DNA; and the optimal operating pH of membrane chromatography was different for the 
plasmid DNAs investigated in this study. The relative contribution of these factors to 
improve membrane chromatography of plasmid DNAs was analyzed using statistical 
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modeling. It was found that the adsorption of plasmid DNA was mainly affected by the 
available adsorptive area associated with membrane porosity, whereas the recovery of 
plasmid DNAs was mainly affected by the environmental pH.  
A novel, RNase-free, and potentially scalable bioprocess was synthesized using the 
hydrogel membrane as the technology platform for the manufacturing of pharmaceutical-
grade plasmid DNA. High bioprocess recovery and product quality were primarily associated 
with the optimal integration of impurity removal by calcium chloride precipitation and anion-
exchange membrane chromatography and the implementation of isopropanol precipitation as 
a coupling step between the two impurity-removing steps. Complete removal of total cellular 
RNA impurity was demonstrated without the use of animal-derived RNase. High-molecular-
weight (HMW) RNA and genomic DNA (gDNA) were removed by selective precipitation 
using calcium chloride at an optimal concentration. Complete removal of the remaining low-
molecular-weight (LMW) RNA was achieved by membrane chromatography using the high-
capacity and high-productive hydrogel membrane. The simultaneous achievement of 
desalting, concentrating and buffer exchange by the coupling step of isopropanol 
precipitation and the high efficiency and resolution of DNA-RNA separation by anion-
exchange membrane chromatography significantly reduced the operating complexity of the 
overall bioprocess, increased the overall recovery of plasmid DNA, and enhanced product 
quality by removing trace amounts of impurities of major concern for biomedical 
applications, such as gDNA, proteins, and endotoxin.  
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1.1 Research Background 
With the advancement in recombinant DNA technology, foreign genes of industrial 
applications can be inserted into plasmid DNA for mass production in various host cells.  
This has resulted in the increasing interest in using plasmid DNA as the vector for the 
delivery of therapeutic genes in gene therapy and DNA vaccination. This approach offers 
great technical advantages as compared to other conventional vectors, such as low production 
cost, high product stability and safety [1]. Recently, several plasmid DNA-based vaccines 
have progressed to clinical evaluations [2], and the ultimate scale of production is huge if 
they are proved to be clinically effective. Although current purification techniques exist for 
plasmid DNA production with end products used mostly in molecular biology work, these 
processes are difficult to scale up and the reagents used in the processes pose safety concerns 
for human applications. Therefore, an efficient downstream bioprocess for the large scale 
manufacturing of plasmid DNA is needed to meet the regulatory requirements for product 
purity, potency and safety. Ultimately, such bioprocess should only use chemicals that are 
generally regarded as safe (GRAS) and be free of animal-derived products (e.g. RNase, 
lysozyme) to produce plasmid DNAs [3].  
Chromatography is considered essential for the purification of high-purity gene 
vectors as it offers high product resolution and uses chemicals that are GRAS [4]. It can be 
operated under various modes, where different physical and chemical properties of plasmid 
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DNA can be explored to achieve separation. Anion-exchange mode is the most commonly 
used amongst them by exploiting the charge density of biomolecules as the basis of 
separation. However, it cannot resolve plasmid DNA from other nucleic acids that are of 
similar charge density. This is especially the case in an RNase-free bioprocess, where HW 
RNA is found to co-elute with plasmid DNA if no other means of RNA reduction is done in 
the upstream. Beside poor resolution, many existing resin-based anion-exchangers suffer 
from poor binding capacity for plasmid DNA, as the small pore sizes (< 30 nm in diameter) 
that were once designed and optimized for protein purification, exclude plasmid DNA (with 
typical hydrodynamic radius around 150-250 nm) from entering the interior adsorptive 
surface [4]. To allow effective use of chromatographic technique for plasmid DNA 
purification, high-capacity membranes with convective “superpores” are developed [5, 6]. 
However, plasmid DNA loss due to irreversible interaction with the hydrophobic membrane 
supports has reduced the efficiency of membrane chromatography. Therefore, new types of 
high-capacity and high-productive membranes are in demand. Although several RNase-free 
bioprocesses have been synthesized based on anion-exchange chromatography, the 
bioprocesses are rather complex and time-consuming, as additional operation units are 
required to accommodate the resulting burden of RNA impurity [7, 8]. In this research, a 
high-capacity hydrogel-based anion-exchange membrane is systematically explored and 
integrated in a novel RNase-free downstream bioprocess to address the issues of low 
capacity, poor resolution from host impurities (e.g. gDNA and HMW RNA) and high 




1.2 Research Objectives 
The overall objectives of this thesis are as follows: 
1. Characterize hydrogel-based strong (Q) anion-exchange membrane, in terms of 
membrane structure, structural integrity and batch adsorption and desorption 
capacities for plasmid DNA.  
2. Identify the factors affecting membrane performance.  
3. Systematically investigate the impact of the intrinsic and extrinsic factors on 
plasmid DNA adsorption and recovery from the membrane. 
4. Develop an efficient and scalable downstream bioprocess for the manufacturing of 
pharmaceutical-grade plasmid DNA using anion-exchange membrane 
chromatography as the final purification step. 
1.3 Outline of the Thesis 
This thesis consists of seven chapters. The scope of each chapter is as follows: 
Chapter 1 gives an introduction to this thesis, including research background, 
research objectives as well as the scope of this thesis.  
Chapter 2 presents a comprehensive literature review on the pharmaceutical 
production of plasmid DNA. 
Chapter 3 investigates membrane structure, structural integrity after multiple cycles 
of usages and batch adsorption and desorption capacities for plasmid DNA.     
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Chapter 4 presents systematic investigation of the impact of the factors on membrane 
performance. 
Chapter 5 presents bioprocess synthesis for the production of pharmaceutical-grade 
plasmid DNA. 
Chapter 6 examines an alternative nucleic acid precipitant, PEG for its potential 
application in downstream bioprocess of plasmid DNA.  
Chapter 7 summarizes the major achievements in this thesis and presents conclusions 







Since the pioneering study of expressing transgenes that were inserted on a plasmid DNA as 
the therapeutic treatment [9], there has been a rapid advancement of plasmid DNA-based 
gene therapy and DNA vaccine development [10-12]. Plasmid DNA therapy is proven to be 
relatively inexpensive and safe to administer. In addition, they have highly stable secondary 
structures that are based on base-pairing hydrogen bonds, making them more stable at 
ambient temperature than conventional viral vaccines and protein therapeutics and this is 
considered as an important advantage during long-term storage [12, 13]. However, due to its 
inherently low infection efficacy, a relatively large dose of plasmid DNA is required [14, 15] 
typically in the order of a few milligrams for a full treatment of a patient [13, 16]. Currently, 
there are several plasmid DNA vaccines marketed or under clinical evaluation for the 
treatment of cancer, infectious and autoimmune diseases. The demand of pharmaceutical-
grade plasmid DNAs will be soaring if they prove to be clinically effective [12]. Therefore, 
an efficient bioprocess that meets the required product purity, potency, and safety standards 
for the large-scale production of plasmid DNA is needed.   
2.1 Properties of Plasmid DNA 
The development of a bioprocess should always start with the thorough understanding of the 
properties of the target molecule and associated impurities, which will be used as the 
rationales for the proper selection of separation techniques. Escherei coli (E. coli) is a 
commonly used host for the production of plasmid DNA, and Table 1 summarizes the 
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characteristics of the components in such a host [17]. The major impurities of concern for 
human therapeutics are gDNA, RNA, protein and endotoxin, and Table 2 outlines FDA 
guidance for the acceptable levels of each impurity [3].  
Table 1 Components of an E. coli cell and their characteristics.  
Species 
Amount 
(% w/w) Avg. MW (kDa) 
water 70 18 
gDNA 0.5 2.8 × 10
6
 
tRNA 4.8 28 
rRNA 0. 9 500-1000 
mRNA 0. 3 660-990 
pDNA < 1 3300
a
 
proteins 15 8-200 
endotoxin 5 10 
others 3 <1 
a= for a plasmid DNA size of 6 kbp 
Plasmid DNAs are double-stranded DNA molecules that carry genetic information 
and exist covalently closed in the bacteria cells. Due to the fact that the phosphate groups in 
the DNA backbone are negatively charged at pH greater than 4 [18], plasmid DNA are 
essentially very large polyanions, making them less physically distinct from host gDNA and 
HWM RNA. On the other hand, LMW RNA and protein are much smaller molecules that 
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can be readily separated from the plasmid DNA base on charge and/or size difference. The 
double helix structure of plasmid DNA coils in space and forms a higher order structure, 
namely the supercoiled isoform. The degree of supercoiling determines the size and charge 
density of plasmid DNA and is dependent on the immediate ionic environment. Other forms, 
such as open circular, linear, denatured or oligomeric ones can also be introduced during 
bioprocessing as the tertiary structure of plasmid DNA is very dynamic and sensitive to the 
potential shear stress encountered during the recovery processes. Studies have shown that 
better therapeutic outcome is associated with high percentage of supercoiled plasmid DNA in 
the dose [1], implying the demand of a bioprocess that favours the production of supercoiled 
plasmid DNA.  
2.2 Bioprocess Synthesis 
There are few heuristics in designing the purification scheme, such as remove the most 
plentiful impurities and easiest-to-remove impurities first, select separation techniques that 
make use of the greatest differences in the properties of the target molecule and associated 
impurities and make the most difficult and expensive separations last.  Figure 1 illustrates a 
generalized block diagram of downstream bioprocess for plasmid DNA manufacturing [19], 
which comprises primary recovery, intermediate recovery and final purification stages. Each 





Table 2 Acceptable criteria for pharmaceutical-grade plasmid DNA and recommended 
assays. 
Impurity Specification Recommended assay 
Plasmid purity >90% sc Agarose gel 
electrophoresis 
Plasmid identity - Restriction digestion 
Agarose gel 
electrophoresis 
gDNA < 0.01 g /g plasmid Quantitative PCR 
RNA Undetectable (< 1%) Agarose gel 
electrophoresis 
Protein < 0.01 g/dose BCA protein assay 
Endotoxin < 0.1 EU/g plasmid  LAL assay 
 
2.2.1 Primary Recovery  
Plasmid DNA is an intracellular component of E.coli, therefore the primary recovery stage 
consists of cell harvesting and cell disruption to release the intracellular content. This stage 
involves significant reduction in bioprocess volume as well as elimination of a huge amount 
of impurities such as extracellular liquid, proteins and gDNA, which is in agreement with the 
heuristics that the most plentiful impurities are removed first. The large-scale cell harvesting 
is usually accomplished by centrifugation and membrane filtration with the preference in the 
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latter, as cell loss during centrifugation is typically 1 to 5% and membrane filtration on the 
other hand is demonstrated to recover essentially all cells.  
 
 
Figure 1 Generalized block diagram of downstream processing. 
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The most critical and troublesome step in downstream bioprocessing is cell 
disruption, where the cells are subjected to external force to break open and release the 
intercellular contents. Since plasmid DNAs and gDNA are shear stress sensitive, the method 
that recovers the highest amount of intact supercoiled isoform with minimum gDNA 
fragmentation should be used to guarantee high overall process yield. Mechanical disruption 
such as high pressure homogenization, bead milling and sonication usually results in 
significant damage to plasmid DNAs, and the usage is not recommended for supercoiled 
plasmid DNA recovery [18]. Enzymatic lysis using lysozyme is commonly seen in 
commercial kits for laboratory work, however, the use of animal-derived enzyme is restricted 
for the production of human therapeutics due to the potential health issues. Chemical 
disruption, such as alkaline lysis is a rather gentle process on the cells, is extensively 
practiced.  
Alkaline lysis was first introduced by Bimboim and Doly [20]. It relies on the use of 
sodium hydroxide (NaOH) and sodium dodecyl sulphate (SDS) to disrupt cells at pH around 
12.2 – 12.4, which results in reversible denaturation of plasmid DNA and irreversible 
denaturation of cell wall material, gDNA and protein. The rationale behind this approach is 
that the alkali environment disrupts the hydrogen bonds that stabilize DNA molecules, as a 
consequence, complementary strands separate from each other. This process is reversible for 
plasmid DNA only if the pH is maintained below 12.5, as the anchor base pairs are preserved 
which will serve as the nuclei for the renaturation of plasmid DNA in the subsequent 
neutralization step. At pH above 12.5, the anchor base pairs may be lost, thus making 
plasmid DNA denaturation irreversible. Therefore, pH should be controlled and local pH 
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extremes (pH > 12.5) should be avoided by sufficient mixing [21]. Also, gentle mixing 
should be applied to avoid excessive shear stress on nucleic acids, which would otherwise 
result in loss of intact supercoiled plasmid DNA and fragmentation of gDNA and HMW 
RNA. Fragmented gDNA and HMW RNA have smaller molecular weight, which are rather 
difficult to precipitate and remove in the subsequent steps, thus co-purified with plasmid 
DNA. Therefore, the efficiency of cell lysis affects subsequent purification processes. On 
large-scale production of plasmid DNA, batch mixing and continuous flow through devices 
have been used to mix resuspended cell paste with lysis buffer. It is claimed that the 
continuous flow through devices introduces lower shear than batch mixing, therefore 
complete, but gentle mixing of large lysis volume can be achieved, where the reaction time 
can be controlled by the residence time in the tubing and pipes [22]. Following alkaline lysis, 
the bioprocess stream is neutralized with potassium acetate for the renaturation of plasmid 
DNAs and the precipitation of denatured gDNA, protein and cell debris together with SDS. 
The precipitated biomass is then removed using solid-liquid separation techniques. 
Centrifuge and microfiltration are two most commonly used techniques, and some other 
options including depth filtration, extraction and expanded-bed adsorption (EBA) 
chromatography are also used [18]. At the end of primary recovery, the fermentation broth is 
eliminated while some purification of plasmid DNA achieved.  
2.2.2 Intermediate Recovery 
After primary recovery, plasmid DNA is presenting as a diluted form in the bioprocess 
stream, therefore volume reduction by concentration becomes the next step in the bioprocess 
to concentrate and further purify the plasmid DNA. Common concentration techniques 
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include selective precipitation, extraction, ultrafiltration and microfiltration. Depending on 
the technique, outcomes such as impurity removal, desalting, plasmid DNA concentration, 
volume reduction and buffer exchange can be achieved.  
Precipitation exploits the changing physical properties of the target molecule upon 
interaction with the precipitants to separate it from the rest. It is usually performed by the 
addition of salts, solvents and polymers, each with their own advantages and disadvantages. 
Salts such as ammonium acetate, ammonium sulphate, sodium sulfate, calcium chloride and 
lithium chloride are used in many purification schemes to selectively precipitate the 
impurities (gDNA, RNA, protein and endotoxin) by reducing their solubility in solution 
while leaving plasmid DNA soluble in the solution. These impurities either have smaller 
molecular size or flexible structure that are more vulnerable to the access of cations into their 
structures as compared to the rigid double-stranded supercoiled plasmid DNA, thus making 
selective precipitation possible [23]. Calcium chloride was experimentally determined to be 
the most potent precipitant for impurity clearance, with impurity reduction of 94%, 96%, 
98% and 91% for RNA, protein, gDNA and endotoxin, respectively [24]. The use of high salt 
precipitation is not without drawbacks, as the presence of salts in the bioprocess stream 
would interfere with many downstream operation units, thus an additional step of desalting is 
often required. Ethanol and isopropanol are well adapted solvents that are used in the 
selective precipitation of plasmid DNA. The addition of these alcohols would reduce the 
dielectric constant of the salt-rich alkaline lysates, which would result in stronger 
electrostatic interaction between cations in the lysates (e.g. K+, Na+) and the negatively 
charged phosphate groups of nucleic acids [25]. As a result, the repulsion between phosphate 
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groups is effectively shielded, resulting in the precipitation of plasmid DNA. Although high 
process yield and product purity were demonstrated with the use of these alcohols [21], the 
limitation is that it necessities the need of explosion proof tanks [18].  
Liquid-liquid extraction using aqueous two-phase systems (ATPS) is also commonly 
performed to isolate plasmid DNA by partitioning biomolecules into different phases [22]. 
Partitioning can be done either in a polymer-polymer or polymer-salt system. There is an 
increasing interest in using polymer-salt system to partition nucleic acids, as such system has 
lower phase viscosities than polymer-polymer system, which makes handling on a large scale 
easier [26]. The most commonly used is the non-toxic PEG-salt system, where PEG 
accumulates in the top phase and salt accumulates in the bottom phase. PEG is a polymer 
with structure of HO[CH2CH2O]nH [27], which sterically excludes itself and other 
biomolecules, this excluded volume effect will have a considerable impact on the solubility 
of nucleic acids [26]. Also, the hydrophilic nature of nucleic acids will be favoured in the salt 
phase [28]. The factors affecting the partition and purification of biomolecules in this system 
include molecular weight and concentration of polymer, type and concentration of salts, ionic 
strength, pH values, tie line length and top to bottom phase volume ratio [29]. Therefore, the 
designing of the system involves systematic variation of the above mentioned factors for the 
desired partitioning behaviour. The main drawback of using PEG-salt system to partition 
nucleic acids is that they are less selective than polymer-polymer systems [26].  
Ultrafiltration and microfiltration exploit the difference in molecular size between 
plasmid DNA and cellular impurities to achieve concentration and separation. The commonly 
used membranes for intermediate recovery of plasmid DNA have molecular weight cut off 
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(MWCO) of 30, 50, 100 and 300 kDa. Although membrane with MWCO of 100-300 kDa 
possess pore sizes that are an order of magnitude smaller than most plasmid DNA, studies 
have shown that the tertiary structure of plasmid DNA can change easily depending on the 
immediate ionic environment and stretch upon hydrodynamic stress and result in passing 
through the membrane [30]. Therefore, the operating condition should be carefully selected 
to ensure minimum loss of plasmid DNA. The selection of smaller MWCO should be 
carefully made in consideration with upstream pretreatments of the clarified lysate, as high 
levels of impurities would result in membrane fouling [31]. In general, the process yield can 
be optimized (80-100%) by carefully selecting the membrane pore size and operating 
conditions for the size of plasmid DNA to be recovered [31, 32].  
Impurity clearance is a major technical advantage of integrating intermediate 
recovery step in the bioprocess. As the viscosity of cell lysate can be greatly reduced, which 
would otherwise cause high-pressure drops, and consequently limit the linear flow rate and 
process throughput for many downstream chromatographic steps [33].  
2.2.3 Final Purification 
Chromatography is commonly used as the final purification step in the large scale 
manufacturing of plasmid DNA. It can be operated in various modes, such as anion-
exchange, reverse-phase, hydrophobic interaction and size-exclusion, which can be used 
singly or combined in many purification schemes [18, 33] to further reduce host impurities. 
The last three modes are primarily used following other chromatographic procedure or as a 
polishing step, whereas anion-exchange is best suited to capture plasmid DNA from the 
bioprocess stream [33]. Due to the physical and chemical similarity between plasmid DNA 
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and host impurities, poor selectivity and co-elution are common problems seen with 
chromatography. If upstream operation units can greatly reduce the impurity level in the 
bioprocess stream, chromatography can then take the advantages of different physical 
properties between plasmid DNA and associated impurities, such as charge density, 
molecular size and hydrophobicity, to achieve final purification. And the selection of 
chromatographic techniques should be made in consideration to the nature and distribution of 
the residual impurities.  
Anion-exchange chromatography takes advantage of the interaction between 
negatively charged nucleic acids and positively charged chromatographic media to capture 
and purify plasmid DNA [33]. The anion exchanger on the chromatographic media can be 
classified as either strong (Q) or weak (D). Strong anion-exchanger, such as quandary 
ammonium, contain strong base and are able to remain positively charged over a wide range 
of pH values. On the other hand, weak anion exchangers such as diethylaminoetheyl (DEAE) 
contain weak base and tend to deprotonated at high pH values, thus having a narrow 
operation range of pH [18]. In both cases, bound nucleic acids are recovered with a salt 
gradient and an elution profile of increasing charge density is generated [33]. It is reported in 
several studies that longer and shallow salt gradients improve the resolution of plasmid DNA 
[34, 35]. This mode of chromatography can readily remove LMW RNA, oligonucleotides 
and some proteins, all of which bear much smaller charge density than plasmid DNA. A 
proposed strategy to achieve separation of low charge density impurities is to load the lysate 
at a sufficiently high salt concentration to avoid impurity adsorption onto the anion-exchange 
media. This strategy comes with an additional advantage of improved capacity for plasmid 
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DNA adsorption [7, 33]. However, large polyanions, such as gDNA fragments, HMW RNA 
and endotoxin may co-purity with plasmid DNA due to their similar charge density and 
adsorptive behaviours. If significant reduction of impurities levels has been done in the 
upstream bioprocessing steps, the plasmid DNA eluted from anion-exchange 
chromatography may be of high enough quality for many uses [33]. One major technical 
disadvantage of many anion-exchange media is the poor binding capacity for plasmid DNAs. 
This is associated with the inadequacy of the pores (< 0.2 m) of most media for the mass 
transfer of plasmid DNA (> 0.2 m).  However, with the introduction of superporosity (> 0.2 
m) in adsorptive membranes [6, 36] and monolith supports [5], convective mass transport 
and improved binding capacity are observed. Table 3 compares some commercially available 
anion-exchange media and their binding capacities for plasmid DNA.  
Table 3 Binding Capacity of plasmid DNA on commercial anion-exchange media. 









Beads      
Q-Sepharose 
Big Beads 
200 - 0.7 4.8 [37] 
Q-Sepharose 
Fast Flow 
90 0.19 1.3 4.8 [37] 
Q-Sepharose 
High 




Q Hyper D 20 0.3 5.4 3.5 [7] 
Fractogel 
EMD DEAE 
40 - 90 0.8 2.45 5.9 [7] 
Poros 50 HQ 50 <0.8 2.12 5.9 [7] 
Monoliths      
DEAE-CIM - 0.01 - 4 10 -  [5] 
Membranes      
Mustang Q - 0.8 10 6.1 [6] 
Natrix 
hydrogel Q 
- 0.45 13 6.4 [36] 
 
Reverse-phase liquid chromatography (RPLC) employs non-polar chromatographic 
media to reversibly interact hydrophobic, non-polar regions of the biomolecules [33]. Bound 
molecules are eluted with decreasing polarity gradients and an elution profile of decreasing 
polarity or increasing hydrophobicity is generated [35]. The selectivity of this 
chromatography can be altered by adding amphiphilic organic ions to chromatographic 
buffer, which forms hydrophobic non-polar ion pairs with polar molecules, such as nucleic 
acids, thus making bounding of polar molecules possible. This form of RPLC is called 
reversed-phase ion-pair chromatography (RPIPC). The major drawback of this technique is 
the use of organic solvents to elute plasmid DNA, which can be toxic, mutagenic and even 
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explosive [38]. As a result, reverse-phase chromatography is rarely used in plasmid DNA 
purification on a large scale for safety concerns.  
Hydrophobic interaction chromatography also exploits surface hydrophobicity of 
biomolecules to achieve separation [33]. Hydrophobicity of nucleic acids varies with size and 
structure, where higher hydrophobicity is expected for nucleic acids with higher content of 
exposed aromatic bases. Intact supercoiled plasmid DNAs are double-stranded nucleic acids 
that are covalently closed, meaning the hydrophobic bases are shielded within the helix; 
whereas RNAs are single-stranded nucleic acids with higher exposure of their hydrophobic 
bases, thus a higher interaction with the hydrophobic media. Endotoxins interact even more 
strongly with the hydrophobic media via lipid A moiety [39]. The binding is promoted by 
salt, thus HIC can be readily performed for salt-enriched cell lysate [22]. One drawback of 
HIC is its low binding capacity, therefore it is usually used as a polishing step operated in a 
condition that favours the retention of impurities and supercoiled plasmid DNA is collected 
in the flow through.  
Size-exclusion chromatography (SEC) separates biomolecules base on molecular size 
[33]. The commonly used media for SEC are Sephacryl S-1000 and Superose 6B (Amersham 
Biosciences), with exclusion limit of 20,000 bp and 450 bp, respectively. Sephacryl S-1000 
can efficiently fractionate plasmid DNA isoforms for plasmid DNA sizes above 10 kbp, 
however, incomplete fractionation occurs for plasmid DNA sizes smaller than 4.4 kbp [40]. 
Operation of Sephacryl S-1000 requires low pressure (< 20 bar) [40], thus it is not suitable 
for cell lysate with high contents of impurity. Otherwise, the process is very lengthy with low 
process throughput. Superose 6B resins, on the other hand,  are more resistant to pressure, 
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where better process yields can be obtained with higher flow rates [40]. Nevertheless, it is 
less tolerant to high impurity levels in the bioprocess stream, and significant reduction in 
impurities in the upstream bioprocess is essential to avoid column overloading. Also, 
resolution of supercoiled plasmid DNA from other isoforms and gDNAs is rather poor as 
compared to Sephacryl S-1000. However, both media do an excellent job as the final 
polishing step following other chromatographic procedures, as the impurities are greatly 
reduced in the upstream and the plasmid DNA is more concentrated [33].  
2.3 Current Bioprocesses for the Manufacturing of Therapeutic Plasmid DNA 
Ideally, an efficient downstream bioprocess should involve the minimum number of 
operation units with the highest possible yield of plasmid DNA and clearance of other host 
impurities per unit of mass of host. In this section, different purification schemes 
representative of current downstream bioprocess (Table 4) for the manufacturing of 
pharmaceutical-grade plasmid DNA are discussed.  
Bioprocess I represents commonly used purification schemes for the production of 
plasmid DNA, which relies on the use of RNase to completely remove RNA impurity in the 
bioprocess stream [41]. RNA is the most abundant host impurity of all, and early elimination 
in the bioprocess stream is desirable to greatly reduce the impurity burden to subsequent 
downstream bioprocess and to simplify the overall bioprocess. However, RNase is an animal 
derived enzyme that is a potential source of mammalian pathogens, and the use of it in 
human therapeutics production is restricted since the outbreak of new variant Creuzfeld-
Jacob disease in the UK [42].  
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Bioprocess II demonstrates an RNase-free bioprocess by integrating high salt 
precipitation, microfiltration and anion-exchange chromatography. Complete resolution of 
plasmid DNA from RNA impurity was achieved by high salt precipitation of HMW RNA 
and TFF and anion-exchange chromatography clearance of LMW RNA. However, the use of 
resin-based chromatography has its disadvantage in poor binding capacity and diffusive mass 
transport, which limit process yield and throughput.  
Bioprocess III is an RNase-free bioprocess, that is designed to purify pNGVL4a-
sig/E7(detox)/HSP70 plasmid DNA vaccine for the treatment of cervical and head & neck 
cancers [43].  It is one of the Developmental Therapeutics Programs taking place at the 
National Cancer Institute (NCI). The bioprocess employs PEG8000 at 8% to selectively 
precipitate plasmid DNA from the alkaline lysate, followed by volume reduction using TFF. 
Plasmid DNA is then captured by anion-exchange chromatography using mustang Q 
membrane and finally polished with SEC using Sephacryl S-1000 for the reduction of gDNA 
and non-supercoiled isoforms of plasmid DNA. One technical advantage of using membrane 
chromatography is that the large pore size of the membrane can accommodate the size of 
plasmid DNA and allows convective mass transport, thus overcoming the limitation of 
diffusive transport as seen with the use of traditional resin-based chromatography [33]. 
Despite high product purity at the end of the process (> 95% supercoiled plasmid DNA), 
significant amount of plasmid DNA (> 60%) was lost during anion-exchange 
chromatography. Thorough investigation of mustang Q membrane was done in another 
study, which also reported low recovery of plasmid DNA [6].  It is suggested that the 
hydrophobic nature of the membrane support caused irreversible adsorption of plasmid DNA. 
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Thus, it is proposed that the process yield can be greatly improved by employing membrane 
material of hydrophilic nature.  
 Bioprocess IV was synthesized to purify pIDKE2 plasmid DNA, which encodes the 
hepatitis C virus (HCV) core, E1, and E2 structural proteins [8]. It completely avoided the 
use of RNase as well as precipitation, and successfully achieved criteria for purity, 
robustness and reproducibility required for the manufacturing of pharmaceutical-grade 
plasmid DNA by integrating microfiltration in TFF mode with several chromatographic steps 
in anion-exchange and size-exclusion modes. Despite demonstrated purity (95% supercoiled 
plasmid DNA) and potency of the final products, the complexity of the bioprocess is 
impractical and labour-intensive for on large scale production.    
 Table 4 Existing bioprocess for the manufacturing of pharmaceutical-grade plasmid DNA. 
Bioprocess Description References 


















III PEG8000 pp 
TFF and detergent wash 
Dissolution and filtration 
Anion-exchange membrane 
chromatography (mustang Q) 
IPA pp 
Dissolution and filtration 
Sephacryl S-1000 chromatography 
IPA pp 
Dissolution and filtration 
[43] 
IV TFF  [8] 
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Sepharose CL 4B chromatography 
G25 coarse chromatography  
Anion-exchange membrane 
chromatography (Sartobind D) 
Sephacryl S-1000 chromatogrpahy 
TFF 
Sterile filtration 
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3.1 Introduction 
Amongst the numerous available methods for plasmid DNA purification, chromatographic 
techniques are widely adopted because they provide high resolution, use only chemicals that 
are GRAS, and are easily scalable [12, 13, 15]. The most commonly used method is anion-
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exchange chromatography which is based on the reversible interaction between negatively 
charged plasmid DNA and the positively charged chromatographic media [13, 44, 45]. The 
application of conventional resin-based anion-exchange chromatography, however, results in 
low adsorption because the small pores in the resin restrict access to near-micron-sized 
plasmid DNAs ( 0.2 m). Resins were originally optimized for the purification of nano-
sized biomolecules such as proteins (2-10 nm) [4, 15, 46, 47]. It was shown by confocal 
microscopy that plasmid DNA adsorption only occurred on the outer surface of the resin and 
this greatly reduced the binding capacity of the resin beads [48]. Of the 10 to 100 grams of 
plasmid DNA loaded per litre of resin, only 0.2 to 2 grams could bind [13]. Thus, a 
substantial amount of chromatographic resin is needed to purify milligrams of plasmid DNA. 
In addition, it is time-consuming and labour-intensive to pack, clean, and regenerate the 
chromatographic column [13, 49]. Studies have also shown low recovery or irreversible 
binding of plasmid DNA to some chromatographic resins [4], either due to the small pore 
size or strong interaction with the resin material.  
Anion-exchange membrane chromatography offers a promising alternative for large-
scale purification of plasmid DNA. It does not involve packing and cleaning procedures 
associated with conventional resin-based chromatography. Most importantly, it allows a 
rapid convective transport of biomolecules through the large pores (~2 m), in contrast to the 
diffusive transport through the small pores of the resins (~0.2 m) [50]. Therefore, a higher 
rate of mass transfer is possible even at high flow rates [4, 50-52]. The large pore size of the 
membrane also allows better accessibility and greater surface area utilization, thus resulting 
in a higher binding capacity. Anion-exchange membranes were shown to surpass at least ten-
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fold the counterpart resins in binding capacity on a per volume basis [6]. The scale-up of 
membrane chromatography is straightforward because the binding capacity is directly 
proportional to the available membrane surface area, while the scale-up of resin-based 
chromatography is more challenging.  
Several studies reported the use of membranes to produce therapeutic plasmid DNAs 
with a high purity but at relatively low yield [8, 51, 53]. For economic reasons, both recovery 
and yield are important aspects that should be maximized to fully realize the advantage of 
membrane chromatography. Employing membrane chromatography, a higher yield of 
plasmid DNA can be achieved with fewer number of processing steps. It is generally 
unacceptable to have a recovery lower than 70% in any single step of a large-scale 
production process [44]. Some studies of plasmid DNA purification using anion-exchange 
membrane addressed these problems. Teeters et al. [6] used different salts and compaction 
agents to reduce the charge density and the size of plasmid DNA in an attempt to improve 
recovery, however, optimal recovery was in the range of 63-76% only. Tseng et al. [54] tried 
to improve plasmid DNA recovery by reducing the binding strength between plasmid DNA 
and the ion-exchange membrane with various alcohols and chaotropic salts in the washing 
buffer. They concluded that recovery was hampered by the irreversible binding of plasmid 
DNA to the membrane support. It is noteworthy that the membrane support in these two 
studies was polyethersulfone polymer, which makes the membrane partially hydrophobic. 
Plasmid DNAs are known to adsorb strongly onto hydrophobic chromatography resins [39]. 
Thus irreversible binding of plasmid DNA to the membrane support was implicated for these 
polyethersulfone-based membranes. Irreversible binding was also observed in another study 
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employing the polyethersulfone-based ion-exchange membrane [54]. It was therefore 
suggested that efforts to improve plasmid DNA recovery should focus on the design of 
membranes employing hydrophilic surfaces [6, 54].  
The objective of this chapter is to explore the characteristics of a hydrogel-based 
strong anion-exchange (Q) membrane that are of important aspects for plasmid DNA 
purification, which include visualization of membrane porous structure at its working 
condition, analysis of structural integrity after multiple cycles of usage and determination of 
maximum adsorption and desorption capacity.  
3.2 Materials and Methods 
3.2.1 Membrane Material 
The membrane explored in this study was a hydrogel-based strong anion-exchange (Q) 
membrane with disk diameter of 25 mm (Natrix Separations Inc., Burlington Ontario, 
Canada). The membrane is made by incorporating 3-acrylamidopropyl-trimethylammonium 
chloride (ATPAC) functionalized macroporous hydrogel polymer onto the polypropylene 
membrane support. The nominal pore size of the membrane is in the range of 0.3 to 0.8 m. 
The crosslinking percentage ranged from 9% to 12%. The 25 mm cut disk has a membrane 
volume of 0.09 ml, and typical mean dynamic BSA binding capacity as determined by the 
manufacturer is 200 mg/ml of membrane volume at a 10% break through value. The two 
sides of the membrane differ in their surface texture, with one side being rougher than the 
other. We thereafter refer to it as the rough side or the smooth side, respectively. 
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3.2.2 Structural Characterization of Membrane Material 
The structural analysis of the membrane was performed using Environmental Scanning 
Electron Microscopy (ESEM, ElectroScan Model E-3, FEI
TM
, Hillsboro, USA). Structural 
visualization was carried out with Oxford INCA 350 Energy dispersive X-ray microanalysis 
system (Oxford Instruments, Oxfordshire, UK). Adsorbent pre-equilibration with 
chromatographic buffer is required for all adsorbent materials used in liquid chromatography, 
and 0.5 h pre-equilibration is recommended by the manufacturer for the hydrogel membrane 
used in this study. To ensure that the hydrogel within the membrane support would reach its 
full swelling potential, 16 h pre-equilibration was also explored and the resulting membrane 
structure was compared to that of conventional 0.5 h pre-equilibration.  The two sides of the 
membrane were visualized before and after pre-treatments.  
3.2.3 Structural Integrity Analysis  
Structural integrity of the membrane can be implied by comparing the flux across the 
membrane after multiple cycles of usage. To perform the analysis, a single layer of 
membrane cut disk (25 mm) was installed in a laboratory-scale (10 ml) stirred cell 
(Millipore, Billerica, USA) that was pressurized by nitrogen to 172 kPa (25 psi) to drive the 
flow of process solution across the membrane. The flux was measured every half hour by 
filtering 10 ml buffer solution containing 50 mM Tris-HCl (pH 8) across the membrane. 
Reversibility of plasmid DNA adsorption (~100 g) onto membranes that were subjected to 




3.2.4 Batch Adsorption and Desorption 
3.2.4.1 Plasmid DNA Preparation 
E. coli cells harbouring pFlag-PalB (6.4 kb) [55] were grown overnight in Luria-Bertani (LB) 
media supplemented with 50 g/ml ampicillin at 37C. Cells were harvested by centrifuging 
the overnight culture at 4000 × g in Hettich Universal 320 R centrifuge (Hettich Instruments, 
Beverly, MA, USA) for 10 minutes. MaxiPreps kit (Bio Basic, Inc., Markham, Ontario, 
Canada) was used to purify plasmid DNA from the harvested cells. Plasmid DNA solutions 
used in the batch experiments were prepared by diluting purified pFlag-PalB stock solution 
with buffer solution containing 50 mM Tris-HCl (pH 8) to various concentrations up to 180 
g/ml. 
3.2.4.2 Batch Adsorption and Desorption 
Small membrane pieces with a cross-sectional area of 0.4 cm
2
 were used in the batch 
experiments. The membrane sheets were added to the plasmid DNA solutions in 1.5-ml 
microcentrifuge tubes and the mixtures were allowed to equilibrate at ambient temperature in 
a shaker incubator (250 rpm) for 16 h. After incubation, the plasmid DNA concentration of 
the liquid phase was measured. The amount of plasmid DNA adsorbed onto the membrane 
was determined by an overall mass balance, and it was expressed as micrograms (mg) per 
cross-sectional membrane sheet area (cm
2
). The batch experiments were conducted in 
triplicate. Using the Metropolis–Hastings algorithm [56], the adsorption data were analyzed 
to evaluate the parameters of the Langmuir isotherm (Equation (1)).  
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                                                       (1)
 
where q is the amount of plasmid DNA adsorbed onto the membrane (µg/cm
2
), c is aqueous 
concentration in equilibrium with the solid phase (µg/ml), qmax is the maximum adsorbed 
plasmid DNA (µg/cm
2
) , and K is the Langmuir equilibrium constant (ml/g). The unbound 
plasmid DNA was washed off by buffer solution containing 50 mM Tris-HCl (pH 8), and the 
elution of the adsorbed plasmid DNAs was carried out by placing the plasmid DNA saturated 
membrane pieces into 1 ml buffer solution containing 50 mM Tris-HCl and 0.8 M NaCl (pH 
8). Desorption was conducted at ambient temperature in a shaker incubator at 250 rpm for 16 
h after which no further desorption was observed.  
3.2.5 Plasmid DNA Quantification 
Plasmid DNA was quantified using NanoDrop spectrophotometer (Thermo Scientific, 
Wilmington, USA) at 260 nm. The absorbance was converted to concentration (ng/l) using 
the Beer-Lambert equation, A = E × b × c, where A is the absorbance, E is the extinction 
coefficient, b is the path length, and c is the concentration. 
3.3 Results 
3.3.1 Membrane Structure 
The two sides of the membrane were visualized under ESEM before and after the pre-
treatment methods, and the resulting membrane structures are shown in Figure 2. The rough 
side of the dry membrane had more fibrous membrane support exposed whereas the smooth 
side had uneven distribution of hydrogel polymer. Also, there were more noticeable pores on 
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the rough side of the dry membrane. The structure of 0.5 h pre-equilibrated membrane was 
similar to that of dry membrane, with the exception of improved distribution of hydrogel 
polymer on the smooth side. However, significant changes in membrane structure were 
observed upon 16 h of pre-equilibration.  The hydrogel completely encased the fibrous 
membrane support and formed deeper, wider and more uniformly distributed pores on both 
sides. The porous structure became more complex on the rough side, where interconnected 
macropores have developed within supermacropores (up to 200 m).  
3.3.2 Membrane Integrity Analysis 
Structural integrity of the membrane after multiple cycles of usage was assessed by 
measuring flux of 10 ml buffer solution across a single layer of membrane cut disk (25 mm) 
at a 0.5 h interval upon contact with aqueous solution and a final measurement was taken at 
16 h. The results are summarized in Figure 3. The filtration flux of 10 ml buffer solution 
upon first contact with aqueous solution was 33.3 ml/min. Despite a slight decrease in flux 
after 2 cycles of usage, the flux was rather consistent at 25 ml/min thereafter. With 
continuous soaking of membrane in the buffer solution, the flux measured at 16 h was 33.3 
ml/min. Figure 4 shows the percentage of plasmid DNA recovery from the membranes that 
were subjected to either 16 h pre-equilibration or multiple cycles of buffer filtration, which 





Figure 2 a) and b) are ESEM images of the rough and smooth side of the dry membrane, 
respectively; c) and d) are ESEM images of the rough and smooth side of 0.5 h pre-
equilibrated membrane, respectively; and e) and f) are the ESEM images of the rough and 





Figure 3 Flux (ml/min) of 10 ml buffer solution across a single layer of membrane cut disk 





Figure 4 Percentage of recovery of pFlag-PalB from 16 h pre-equilibrated membrane and 
membrane subjected to multiple cycles of buffer filtration. 
3.3.3 Batch Adsorption and Desorption 
The static adsorption capacity of the membrane was determined by analyzing the parameters 
(qmax and K) of Langmuir adsorption isotherm using Metropolis-Hastings algorithm. The 
adsorption isotherm of pFlag-PalB is shown in Figure 5. The maximum amount of plasmid 
DNA adsorbed onto the membrane (qmax) and the Langmuir equilibrium constant (K) were 
found to be 227 g/cm
2
 (12.4 mg/ml membrane volume) and 7.4 10
-2
 ml/g, respectively. 
Reversibility in plasmid DNA adsorption was assessed by eluting the adsorbed plasmid DNA 
from the membrane in a batch mode. Results from previous chromatographic experiments 
performed with a gradient elution using buffer containing 0 M to 2 M NaCl have shown that 
an elution buffer containing at least 0.6 M NaCl was needed to elute plasmid DNA from the 
membrane. Experiments were also performed with a step-wise elution scheme, where an 
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elution buffer containing 0.8 M and 2 M NaCl was used stepwise to see if further elution is 
possible beyond 0.8 M NaCl. It appears that the majority of the plasmid DNA was eluted 
with a buffer containing 0.8 M NaCl and further elution with 2 M NaCl did not improve 
recovery. Therefore, an elution buffer containing 0.8 M NaCl was chosen to desorb plasmid 
DNA from the membrane. Desorption process was carried out overnight until no further 
change in concentration was observed, and the average recovery was ~ 90%.  
 
 
Figure 5 Batch adsorption isotherm of pFlag-PalB (6.4 kb) onto hydrogel Q membrane in 




The characterization of membrane structure and performance is an important step in 
assessing the suitability of a particular membrane for the separation of biomolecules of 
interest, therefore membrane structure, structural integrity after multiple cycles of usage as 
well as the adsorption and desorption capacities were characterized for the hydrogel 
membrane used in this study. 
 ESEM was chosen to visualize membrane structure in this study for its ability to 
characterize sample in wet state, therefore the image is more reflective to the membrane 
structure at its working condition. In comparison to some other microscopic methods (e.g. 
Scanning Electron Microscopy), sample pre-treatment is not required for ESEM, therefore 
potential artifacts that would be introduced during sample preparation was avoided. 
Chromatographic membranes are usually preserved and shipped in a dehydrated state. 
According to the manufacturer’s recommendation, the membrane should be pre-equilibrated 
in the chromatographic buffer for at least 0.5 h prior to use. However, it was noted that the 
typical porous structure of hydrogel-based membranes was under-developed after 0.5 h pre-
equilibration and further swelling and continual pore development were observed upon a 
longer contact with the aqueous environment (16 h). The resulting membrane showed 
improved distribution of hydrogel as well as the resulting porous structure; therefore 
membrane pre-equilibrated in buffer solution for 16 h will be providing a better flow through 
channel for biomolecule separation.   
The consistent filtration flux as well as the preservation of reversible adsorption of 
plasmid DNA after multiple cycles of buffer filtration suggested that the hydrogel membrane 
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used in this study possess good structural integrity, which is suitable for usage in downstream 
chromatography where a multiple-cycle mode is required. The improvement in filtration flux 
with continuous soaking of the membrane in the buffer solution (16 h) confirmed the 
advantage of 16 h membrane pre-equilibration for the development of better flow through 
channel. 
The selection of the chromatographic material for the economic production of 
pharmaceutical-grade plasmid DNA is generally based on the adsorption capacity and 
reversibility. Therefore, the maximum plasmid DNA adsorption and desorption capacity of 
the membrane were investigated in a series of batch experiments. The maximum adsorption 
capacity is 227 g/cm
2
 cross-sectional membrane area or 12.4 mg/ml membrane volume. The 
capacity is 6 times higher than that of commercially available resin [13]. It is also notable 
that the adsorption capacity for plasmid DNA of similar linear size (~ 6 kb) was much higher 
than that of other commercially available Q membranes [57]. The average recovery was ~ 
90%. The unrecovered plasmid DNA might be physically entrapped within the polymeric 
support as the hydrogel shrinks in solution of high ionic strength that is used to elute plasmid 
DNAs, or irreversibly adsorbed onto the membrane due to non-specific interaction caused by 
the high ionic strength of the elution buffer. Despite an incomplete desorption, the average 
recovery from the hydrogel membrane was substantially higher than the previously reported 
recoveries at 63-76% using various elution buffers containing salts and compaction agents 
[57]. It is postulated that the high adsorption and desorption capacities are the inherent 
property of the present hydrogel-based membrane adsorbent. The batch adsorption 
experiments were carried out by incubating membrane and plasmid DNA in the loading 
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buffer for 16 h, which was long enough for the hydrogel-based membrane to completely 
encase the hydrophobic membrane support and develop a more porous structure with a 
greater accessible adsorptive area (Figure 2 e and f). A comparison between hydrogel Q 
membrane used in study and some other chromatographic adsorbent is summarized in Table 
5.   
Table 5 Adsorption and desorption capacity of some anion-exchange chromatographic 
adsorbent.  
Adsorbent qmax (mg/ml) % 
recovery 
References 
Hydrogel Q 12.7 90% [36] 
Mustang Q 10 60-70% [6] 
Q-Sepharose High 
performance 
2.5 - [7] 






Investigation of Factors Affecting Membrane Performance 
















 and C. Perry Chou
a,*2
 
Declaration: I initiated and conducted all experiments presented in this chapter under the 
supervision of Dr. C. Perry Chou, Dr. Jeno Scharer and Dr. Murray Moo-Young. 
 
4.1 Introduction 
In light of many technical advantages associated with the use of membrane chromatography 
for plasmid DNA purification, thorough understanding of the factors affecting membrane 
performance is the objective of this chapter for the determination of the operating conditions 
that favour an economic manufacturing of plasmid DNA.   
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It is known that the binding capacity of chromatographic media is in linear 
relationship with the available adsorptive area [44], which is a function of membrane surface 
porosity. As characterized in the previous chapter (Figure 2), the hydrogel membrane used in 
this study has different porosity between the two sides and the porosity is greatly improved 
with extensive membrane soaking (16 h).  Therefore, membrane performance as a result of 
different combination of membrane orientation in the chromatographic unit and membrane 
pre-equilibration time was investigated. Due to the fact that separation using anion-exchange 
chromatography is based on the surface charge density of biomolecules, it is expected that 
small plasmid DNAs bearing less surface charge density would have minimal interaction 
with the membrane and better transport thru the porous structure, thus a higher process 
recovery.  It is also known that the degree of supercoiling is affected by the immediate ionic 
environment [58]. Therefore, membrane performance was also compared for plasmid DNAs 
with different tertiary sizes at various pH values. And the contribution of each factor to 
membrane performance was statistically evaluated.  
And this is the first time ever that systematic investigation of both intrinsic and 
extrinsic factors was done for the hydrogel membrane used in this study.  
4.2 Materials and Methods 
4.2.1 Preparation of Plasmid DNA 
Plasmid DNA of pUC19 (2.7 kb) [59], pET20b(+) (3.7 kb) [60] and pFlag-PalB (6.4 kb) [55] 
were prepared similarly as described in section 3.2.4.1. The plasmid DNA feed for 
membrane chromatography experiments was prepared by diluting the purified plasmid DNA 
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to 50 g/ml in the loading buffer (as described in section 4.2.2) at a desired pH. Same 
amount of plasmid DNA (~ 110 g) was loaded onto the membrane for all experiments.  
4.2.2 Chromatographic Buffers 
The loading and washing buffers were 50 mM Tris-HCl, and the elution buffers contained 
either 0.8 M or 2 M NaCl in addition to 50 mM Tris-HCl. All buffers were prepared in 18 
M deionized water and adjusted to pH 7, pH 8, or pH 9.   
4.2.3 Membrane Chromatography 
Membrane chromatography in this study was conducted using a laboratory-scale (10 ml) 
stirred cell (Millipore, Billerica, USA), which was pressurized by nitrogen to 172 kPa (25 
psi) to drive the flow of the plasmid DNA solution across the membrane. For each 
experiment, a single layer of the pre-treated membrane was overlaid in the stirred cell. 
Plasmid DNA solution at 2 ml was loaded onto the membrane and was pressure-driven 
through the stirred cell. As shown in Figure 6, plasmid DNA is subject to four possible 
outcomes upon loading to the membrane, i.e. (1) flow through the membrane, (2) adsorb onto 
the membrane reversibly, (3) adsorb onto the membrane irreversibly, and (4) be rejected by 




Figure 6 Potential outcomes of plasmid DNA upon loading to the membrane 
The amount of plasmid DNA adsorbed onto the membrane was determined by an overall 






FTRL 100                                                  (2) 
where PL is the amount of plasmid DNA loaded to the membrane, PR is the amount of 
plasmid DNA rejected by the membrane, PFT is the amount of plasmid DNA flowing through 
un-adsorbed, and (PL - PR - PFT) is the amount of plasmid DNA adsorbed onto the membrane. 
After loading the plasmid DNA, the membrane was washed with 2 ml of washing buffer, 
followed by step-wise elution scheme with elution buffers containing 0.8 M and 2 M NaCl. 
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The percentage of plasmid DNA being recovered from the membrane was calculated using 









                                               (3) 
where PEi is the amount of plasmid DNA eluted in the ith elution fraction, and  PEi  is the 
total amount of plasmid DNA recovered from the membrane during the elution. The 
irreversibly adsorbed plasmid DNA onto the membrane was determined by the difference 












                                        (4) 
where PAds (= PL - PR - PFT) is the total amount of plasmid DNA adsorbed onto the 
membrane, PAds - PEi is the amount of plasmid DNA irreversibly adsorbed onto the 
membrane, and the rest of the variables are the same as those in Equations (2) and (3).  
4.2.4 Experimental Design 
The intrinsic and extrinsic factors that would affect membrane performance were identified, 
which are plasmid DNA size, membrane orientation in the filtration unit, membrane 
pretreatment methods and pH of chromatographic buffers. The tertiary structure of three 
plasmid DNAs with different molecular sizes (2.7 kb to 6.4 kb) was compared using agarose 
gel electrophoresis (as described in section 4.2.5). Then, the effect of tertiary structure was 
related to membrane chromatography performance. To determine the optimal operating 
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condition of membrane chromatography, these factors were examined using fractional 
factorial design and their investigated levels are summarized in Table 6. The experiments 
were replicated for each combination of conditions.  







Level 1 Rough 0.5 h 7 
Level 2 Smooth 16 h 8 
Level 3 - - 9 
 
4.2.5 Analytical Methods 
The concentration of plasmid DNA was quantified using NanoDrop spectrophotometer as 
described in section 3.2.5. In addition to the spectroscopic analysis, some plasmid DNA 
samples were also analyzed by agarose gel electrophoresis for comparison. To perform the 
analysis, samples were loaded to a 1% agarose gel for electrophoresis at 100 V for 60 min. 
Then, the agarose gel was stained with ethidium bromide and visualized using a UV 
transilluminator. The image of the agarose gel was taken by a digital camera, and the 
intensity of each band was scanned and quantified using an image processor (Image J 
software from National Institutes of Health, http://rsbweb.nih.gov/ij/). Using these quantified 




4.3.1 Plasmid DNA Size 
The tertiary structure of three plasmid DNAs with different molecular sizes, namely 
pET20b(+) (3.7 kb), pFlag-palB (6.4 kb) and pUC19 (2.7 kb), was compared by agarose gel 
electrophoresis at pH 8 and the results are shown in Figure 7. Despite length of primary 
sequence, pET20b(+) had the smallest tertiary structure, followed by pFlag-PalB, and pUC19 
has the largest tertiary structure (Figure 7 a). The average recovery of pET20b(+), pFlag-
PalB, and pUC19 at pH 8 from the 16-h pre-equilibrated  membrane was 89%, 75%, and 
65%, respectively (Figure 7 b), which follows the order of their tertiary sizes from the 
smallest to the largest. 
4.3.2 Surface Texture and Membrane Orientation  
Orientation is another important consideration as the hydrogel membrane used in this study 
differed in its surface porosity on the two sides. To assess the effect of surface porosity, 
plasmid DNA adsorption and desorption of pET20b(+) were compared for membrane 
orientation with either the “rough” or “smooth” side upward in the chromatographic unit. As 
determined previously, membrane performance is dependent on the tertiary size of plasmid 
DNA, therefore,  pET20b(+), a relatively small plasmid DNA in comparison to the other 
plasmid DNAs was chosen for the purpose of this experiment as it is expected to minimize 
the effect of plasmid DNA size on membrane performance. Therefore, any difference seen in 





Figure 7 a) Agarose gel electrophoresis of pET20b(+) (lane 4), pFlag-PalB (lane 5) and 
pUC19 (lane 6), and b) averaged percentage recovery of pET20b(+), pFlag-PalB and pUC 19 
at pH 8 with 16 h pre-equilibrated membrane. 
The amount of rejected and recovered plasmid DNA was quantified using NanoDrop 
spectrophotometer, and the results are summarized in Table 7. There was significantly more 
plasmid DNAs being adsorbed and recovered if the membrane was oriented with the rough 
side upward in the chromatographic unit. The average rejection of pET20b(+) from the rough 
and smooth side was 20.5% and 68.0%, respectively. This significant difference in plasmid 
DNA rejection was also confirmed by agarose gel electrophoresis analysis. As shown in 
Figure 8 a, the band intensity of the rejected plasmid DNA was very faint as compared to that 
of plasmid DNA feed, suggesting only a small fraction of the feed was rejected if the rough 
side was installed upward. In the case where the smooth side was installed upward (Figure 8 
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b), the band intensity of the rejected plasmid DNA was as bright as the feed, suggesting a 
majority of the feed was rejected. Densitometric analysis of the agarose gel image was 
performed using Image J for the quantification of plasmid DNA recovery and rejection. The 
results were consistent with those obtained by spectrophotometric analysis (Table 7). The 
flux of plasmid DNA solution across the membrane was also higher during each step of 
chromatography if the membrane was installed with rough side upward, the difference was 
significant during loading and elution steps.    
Table 7 Comparison of averaged percentage adsorption, averaged percentage recovery  and 
flux of loading, washing and elution step between experiments using the rough side and the 
smooth side of the membrane as the plasmid DNA loading surface for pET20b(+) at pH 8 






















Rough 79.5  1.3 77.0  
1.6 
8.4  0.3 5.0  0.2 67.9  0.0 
Smooth 32.0  1.4 67.5  
0.7 





Figure 8 Agarose gel electrophoresis of samples taken from various steps of chromatographic 
experiments a) using rough side of the membrane as the plasmid DNA loading surface, and 
b) using smooth side of the membrane as the plasmid DNA loading surface. In both gels, lane 
1 is DNA marker, lane 2 is plasmid DNA feed, lane 3 is the frontal side of membrane after 
loading and before washing, lane 4 is the frontal side of membrane before first elution with 
elution buffer containing 0.8 M NaCl , lane 5 is the first elution flowthrough, lane 6 is the 
frontal side of the membrane before second elution, lane 7 is the second elution flowthrough 
and lane 8 is the third elution flowthrough. Arrow in both gels is pointed at the band 
corresponding to rejected plasmid DNA.  
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4.3.3 Membrane Pre-treatment and Buffer pH 
Previous experiments have demonstrated advanced porous structure formation with extensive 
soaking in the buffer solution (Figure 2), therefore membrane pre-treatment involving 
conventional 0.5 h and 16 h pre-equilibration in the loading buffer were compared for their 
effectiveness in plasmid DNA adsorption and desorption of pET20b(+), pFlag-PalB and 
pUC19. The results are summarized in Figure 9. 
The average adsorption of pET20b(+), pFlag-PalB, and pUC19 by the conventional 
membrane pretreatment (0.5 h pre-equilibration) was 73%, 68%, and 50%, respectively. The 
adsorption of pET20b(+) and pFlag-PalB was improved to 96% if the membrane was pre-
equilibrated for 16 h. There was no difference in the adsorption of pUC19 between 0.5 h and 
16 h pre-equilibrated membrane if membrane chromatography was performed at pH 7; 
however, the adsorption was improved to 97% upon 16 h pre-equilibration at both pH 8 and 
pH 9. The application of 16 h pre-equilibration resulted in an almost complete adsorption (> 
96%) of all the plasmid DNAs tested in this study, whereas the adsorption onto the 0.5 h pre-




Figure 9 Comparison of the averaged percentage adsorption and recovery of a) pET20b(+), 
b) pFlag-PalB and c) pUC19 between experiments using 0.5 h and 16 h pre-equilibrated 
membranes at pH 7, pH 8 and pH 9. 
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Reversibility in plasmid DNA adsorption was also assessed. The highest recovery of 
all plasmid DNAs occurred if 16 h pre-equilibrated membrane was used (Figure 9). 
However, the highest recovery of pET20b(+) and pFlag-PalB occurred if membrane 
chromatography was performed at pH 8, whereas the highest recovery of pUC19 occurred at 
pH 9. For an economic production of plasmid DNA, irreversible adsorption should be kept at 
a minimum. It is noteworthy that the pH at which the least amount of irreversible adsorption 
occurred was the pH where the highest recovery was observed (Figure 10). Also, plasmid 
DNAs with smaller tertiary structure had lower levels of irreversible adsorption. Hence, 
factors affecting membrane porosity and plasmid DNA charge density should be considered 
to minimize irreversible adsorption for an economic production of pharmaceutical-grade 




Figure 10 Percentage of irreversible adsorption of a) pET20b(+), b) pFlag-PalB and c) 
pUC19 to the membranes that were either soaked for 0.5 h or 16 h at pH 7, pH 8 and pH 9. 
4.3.4 Factorial Contribution to Membrane Performance  
Since all factors investigated herein appeared to be relevant to membrane performance, it 
would be valuable to obtain the contributing level of each factor for any future improvement 
of membrane design. Therefore, the relative contribution of various factors, including 
membrane orientation, membrane soaking time, and chromatographic buffer pH, to the 
performance of membrane chromatography was determined using fractional factorial 
analysis. The results are summarized in Figure 11. Note that the contribution of each factor to 
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the recovery was evaluated for all three plasmid DNAs (Figure 11 a, b and c). However, a 
similar evaluation associated with the adsorption behavior was evaluated for pET20b(+) only 
(Figure 11 d) since the experiments were performed at more levels of the membrane 
orientation factor only for this plasmid DNA. Factorial design allows the determination of the 
effect of a given factor at several levels of the other factors so that the conclusions are valid 
over a range of experimental conditions [61]. The fractional factorial experiments comprised 
a 2×2×3 level (orientation × soaking time × buffer pH) design (Table 6). The three-factor 
interactions were confounded; consequently the main effects and the two-factor interactions 
were evaluated. Based on the analysis, the interactions between the factors were 
insignificant. The main effects “explained” 80% or more of the total variability. Evidently, 
the response at the “best” buffer pH was not dependent on either the orientation of the 
membrane or the length of membrane pre-equilibration. In a similar vein, membrane 
orientation and pre-equilibration time appeared to be independent variables with minimal 
interaction. For both pET20b(+) and pFlag-PalB, the effect of the buffer pH on the recovery 
was significantly greater than that of the membrane pre-equilibration time and membrane 
orientation. However, the effect of the buffer pH and membrane orientation on the recovery 
of pUC19 was minor, as compared to the effect of the membrane soaking time. One can 
conclude that the recovery of plasmid DNAs with a small tertiary structure is mostly 
influenced by the buffer pH, whereas the recovery of plasmid DNAs with a large tertiary 
structure is mainly dependent on the membrane pore size. For the adsorption of plasmid 
DNAs (Figure 11 d), the effect of membrane orientation was the greatest, followed by the 
membrane pre-equilibration time, while the buffer pH has the smallest effect. It is 
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noteworthy that the combination of membrane orientation and pre-equilibration time 
determines the available adsorptive area of the membrane; therefore, the adsorption of 
plasmid DNAs was primarily dependent on the available adsorptive area of the membrane. 
The result is consistent to previous observations [4, 53].  
 
Figure 11 The relative contribution of membrane soaking time, pH of the buffer and the 
orientation of the membrane to plasmid recovery of a) pET20b(+), b) pFlag-PalB, c) pUC19, 
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and d) the relative contribution of the above mentioned factors to plasmid adsorption of 
pET20b(+) to the membrane. 
4.4 Discussion  
Membrane chromatography is promising to overcome several major challenges associated 
with the large-scale production of plasmid DNAs. In this study, the high-capacity hydrogel-
based Q membrane was used to demonstrate its potential applicability for plasmid DNA 
purification. While the desired property in membrane chromatography is reversible 
adsorption, rejection and irreversible adsorption of plasmid DNAs can be frequently 
observed. Using the hydrogel-based membrane, the extent to which these undesirable events 
occurred was found to be dependent on various factors, such as tertiary structure of plasmid 
DNA, membrane porosity, membrane pre-equilibration time, and pH of chromatographic 
buffers.  
The tertiary size of plasmid DNA, as determined by the primary sequence and the 
degree of supercoiling had an effect on membrane performance, where a higher adsorption 
and recovery were seen for plasmid DNA of smaller tertiary structure. Plasmid DNAs with a 
small tertiary structure have a short hydrodynamic radius so that they will be less restricted 
by the pores of the membranes.  Also, they tend to have a lower surface charge density than 
plasmid DNA with a large tertiary structure, thus forming a fewer number of interactions 
upon loading to the anion-exchange chromatography. The experimental results of this study 
and other studies [23, 30, 53, 62, 63] were consistent in terms of the observation of higher 
recovery associated with small plasmid DNA size using anion-exchange membrane 
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chromatography. From a bioprocessing viewpoint, it will be desirable to use plasmid DNA of 
a smaller tertiary structure as the vector for gene therapy and DNA vaccinations. 
Porosity appears to have a major impact on membrane performance. In this study, 
porosity is determined by membrane orientation and membrane pre-equilibration time. 
Higher adsorption, recovery and flux of plasmid DNA associated with installing the more 
porous side (rough side) of the membrane upward in the chromatographic unit is explained 
by the fact that the more porous side would provide a larger accessible area for plasmid DNA 
adsorption, thus the rejection due to the restrictive membrane pore size and the repulsion by 
the previously bound plasmid DNA could be minimized. It was shown previously that the 
porosity can be greatly increased by pre-equilibrate the hydrogel membrane in buffer solution 
for 16 h. With the pre-treatment, pores were enlarged, well-structured, and evenly distributed 
so that the adsorption capacity for plasmid DNA could be substantially enhanced. In 
addition, the hydrophilic supermacroporous hydrogel could completely encase the membrane 
support and the irreversible adsorption of plasmid DNA to the hydrophobic membrane 
support was reduced. The approach greatly reduced plasmid DNA loss associated with the 
irreversible adsorption to the membrane support that is commonly observed for many 
commercially available anion-exchange membranes. The enlargement in pores would further 
increase the accessible adsorptive area, thus resulting in less intermolecular competition of 
the plasmid DNA for the membrane binding sites. Also, the electrostatic repulsion of 
incoming plasmid DNA by the previously captured material on the membrane was expected 
to be minimized by the well developed porous structure, resulting in further reduction in the 
amount of plasmid DNA being rejected. This could prevent, in turn, the possible formation of 
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a filter cake layer at the frontal side of the membrane, which would otherwise lower the 
binding capacity and reduce the operational throughput. There was a greater improvement in 
recovery of pUC19 with the use of 16 h pre-equilibrated membrane as compared to the other 
two smaller plasmid DNAs, suggesting a greater impact of membrane porosity on the 
recovery of plasmid DNAs with a larger tertiary structure.  
Unlike adsorption where the capacity was mainly influenced by the porosity of the 
membrane, desorption was also affected by the electric interaction between the strong anion-
exchange hydrogel and plasmid DNA, which can be manipulated by the ionic environement. 
Therefore, reversibility was also compared at various pH values (i.e. pH 7, pH 8, and pH 9). 
The pH of chromatographic buffer had a more pronounced impact on desorption behaviour 
of plasmid DNA than other factors because it could potentially affect the size of the tertiary 
structure of plasmid DNA and/or surface charge density. Through a careful selection of the 
operating pH, the recovery can be further improved. The optimal pH appeared to be plasmid 
DNA-dependent. The use of a chromatographic buffer at pH 8 resulted in the highest 
recovery for pET20b(+) and pFlag-PalB, whereas the highest recovery of pUC19 was 
observed using a chromatographic buffer at pH 9. It is proposed that plasmid DNAs may 
have a smaller tertiary structure (due to supercoiling) and/or a lower overall surface charge 
under these pH conditions, which would result in less interaction with the membrane, thus in 
a higher recovery as compared to other (less favourable) pH values. It appears that the most 
favourable pH for reversibility varies with plasmid DNA, therefore the operating pH should 
be carefully determined for each individual plasmid. 
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The flux was also improved for all three plasmid DNAs if 16 h pre-equilibrated 
membranes were used (data not shown). The high convective flow through the 
supermacroporous structure of the hydrogel membrane, as compared to the diffusive 
transport through the interior of the resin beads, would be an important processing benefit for 
large-scale production. It is important to have a high throughput in addition to a high 
recovery and yield, and using the rough side of 16 h pre-equilibrated membrane to purify 





Bioprocess Development  
The work in this chapter was included in “Developing an RNase-free bioprocess to 
produce pharmaceutical-grade plasmid DNA using selective precipitation and membrane 
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Prior to the recent high demand of plasmid DNA for medical applications, technologies for 
plasmid DNA purification were well established only for small-scale applications,  
particularly in molecular biology. In addition to the limitation of scalability, these available 
technologies are unsuitable for the production of pharmaceutical-grade plasmid DNA as they 
often involve the use of toxic chemicals and animal derived products [64]. In particular, 
RNase, derived from bovine pancreas, is generally used to degrade RNA that is otherwise 
difficult to separate from plasmid DNA, but its usage raises safety concerns in view of the 
new variant Creuzfeld-Jacob disease outbreak in the UK [42]. The restricted use of RNase 
for the production of pharmaceutical-grade plasmid DNA places a great challenge on 
downstream bioprocessing, therefore, effective RNA removal prior to chromatography 
becomes necessary. Several studies reported promising clearance of RNA impurities without 
the use of RNase [7, 8, 65]. While the use of tangential flow filtration (TFF) in combination 
with resin-based column chromatography demonstrated complete clearance of RNA [8], this 
bioprocess was rather time-consuming and labour-intensive, particularly for large-scale 
production. Selective precipitations using salts are rather simple and inexpensive operations 
for impurity removal and are often implemented as an intermediate recovery step [21]. They 
are promising for RNA removal, especially HMW RNA that is otherwise difficult to separate 
from plasmid DNA by anion-exchange chromatography [66, 67]. As shown in a comparative 
study for evaluating the potential of five antichaotropic salts to precipitate RNA, calcium 
chloride was found to be the most potent precipitant [24]. It was suggested that, by properly 
coupling selective precipitations and anion-exchange chromatography, the polishing step 
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might not be required, since the derived plasmid already has a quality level suitable for many 
applications [21]. This was demonstrated in a study where the purification bioprocess 
involved the use of calcium chloride precipitation, TFF, dialysis, and anion-exchange column 
chromatography [7]. Nevertheless, these potentially tedious purification steps would be a 
hindrance for large–scale and economic production.  
Existing methods for the purification of plasmid DNA rely mainly on 
chromatography, employing size-exclusion, reverse-phase, ion-exchange and hydrophobic 
interaction resins [33]. Of these, anion-exchange chromatography remains the most common 
method as it employs reversible interaction between negatively charged biomolecules and 
positively charged chromatographic media. It offers rapid separation and uses chemicals that 
are generally considered safe [21, 33]. With the development of membrane chromatography, 
the anion-exchange mode of separation has received greater attention as the relatively large 
pores (~2 µm) of the membrane allow convective mass transfer and provide a higher capacity 
for plasmid capture [33, 36]. Most importantly, membrane chromatography is scalable as the 
binding capacity is directly proportional to the available membrane surface area. However, 
most chromatographic techniques, including anion-exchange membrane chromatography, 
suffer from low resolution between plasmid DNA and undegraded RNA [68]. Although high 
purity of plasmid DNA can be obtained with size-exclusion chromatography (SEC) [69], the 
bioprocess scale-up is limited by the slow linear flow rate required for an optimal resolution 
[21]. Also, the small loading volume and the requirement of RNA-reduction steps (using 
isopropanol, ethanol, ammonium acetate, polyethylene glycol or calcium chloride) make 
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SEC suitable only as a polishing step following other high-capacity chromatographic steps 
[8, 18, 69].  
In the previous chapter, we reported various technical advantages associated with a 
hydrogel membrane for the purification of plasmid DNA [36]. In this chapter, we 
demonstrate its potential application by developing a simple and yet effective RNase-free 
bioprocess for the production of pharmaceutical-grade plasmid DNA with a high bioprocess 
yield. The combined use of selective precipitation by calcium chloride and membrane 
chromatography by hydrogel membrane is proposed for the first time to remove total cellular 
RNA. In addition, we explore the use of isopropanol as a promising coupling step for 
simultaneous desalting, concentrating, and buffer exchange of the process stream. The 
clearance of impurities of major concern for biomedical applications, such as gDNA, proteins 
and endotoxin, is also demonstrated.  
5.2 Materials and Methods 
5.2.1 Bacteria Growth and Lysis 
E.coli DH5α cells harbouring pET20b(+) (3.7 kb) [60] were grown and harvested as 
described in section 3.2.4.1. The cell pellet was resuspended in 3 ml of 50 mM Tris-HCl and 
10 mM EDTA solution (pH 8.0), followed by cell lysis using a modified alkaline lysis 
method as described by Birnboim and Doly [20]. Alkaline lysis was gently performed by 
adding 3 ml of 200 mM NaOH and 1% (w/v) sodium dodecyl sulphate solution, then 6 ml of 
pre-chilled 3 M potassium acetate (pH 5.5) was used to neutralize the lysate for the 
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precipitation of cellular debris, genomic DNA and proteins. The precipitate was then 
removed by centrifuging at 16,000 × g for 10 minutes at room temperature.  
5.2.2 Optimization of Calcium Chloride Precipitation for the Clearance of HMW RNA 
The main purpose of this intermediate recovery step is to remove HMW RNA that is difficult 
to resolve from plasmid DNA using anion-exchange chromatography. To determine the 
concentration range of calcium chloride for the optimal removal of HMW RNA with 
minimal loss of plasmid, the clarified lysate was divided into 5 aliquots of equal volume, 
then calcium chloride stock solution (4 M) was added accordingly to reach a final 
concentration of 0.5, 1, 1.5, 2 and 3 M, respectively. The precipitated material including 
RNA, gDNA, protein and endotoxin was removed by centrifugation at 16,000 × g for 10 
minutes after incubation at room temperature for 10 minutes. The supernatant from each 
precipitating concentration was collected and desalted using 60% (w/v) isopropanol, then 
analyzed by agarose gel electrophoresis followed by Image J densitometric measurement (as 
described in section 2.3.1) to evaluate plasmid DNA recovery and RNA clearance.  
5.2.3 Optimization of Isopropanol Precipitation as the Desalting Step 
Isopropanol is often used as a nucleic acid precipitant  in the downstream bioprocess [70]. 
This feature can be used to couple the two major RNA clearance steps of calcium chloride 
precipitation and membrane chromatography by removing interfering salt content from the 
clarified lysate. The operating concentration of isopropanol was determined based on the 
precipitation profiles [65]. After adding the precipitant to cell lysate, the mixture was 
immediately centrifuged at 16,000 × g for 15 minutes at room temperature, followed by 
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washing with 70% (v/v) ethanol and centrifugation at 16,000 × g for 10 minutes at room 
temperature. The pellet was then resuspended in a loading buffer (as described in section 
4.2.2). The same amount of cell lysate from a batch culture was used for all precipitation 
experiments. Plasmid DNA recovery and RNA clearance were evaluated by agarose gel 
electrophoresis and Image J densitometric analysis (as described in section 4.2.5).  
5.2.4 Optimization of Membrane Chromatography for the Clearance of LMW RNA 
Membrane chromatography was performed using BioLogic LP system with BioFrac fraction 
collector (Bio-Rad Laboratories Ltd.). Absorbance (280 nm) and conductivity were recorded 
using LP data view V1.03 software (Bio-Rad Laboratories Ltd.). Anion-exchange membrane 
was installed in a 25 mm stainless steel membrane disc holder (Natrix Separations, Inc.) that 
was integrated into BioLogic LP system. A single layer of membrane was used for each 
purification experiment, and it was installed with rough surface upward in the filtration unit 
for a better membrane performance and process yield [36]. The BioLogic LP system was 
programmed to pre-equilibrate the membrane with 15 ml loading buffer, followed by sample 
loading.  The membrane was then washed with washing buffer, and the adsorbed plasmid 
DNA was recovered using gradient salt (NaCl) concentration. The ionic strength of the 
washing buffer was selected at the salt concentration which resulted in an optimal elution of 
impurities such as RNA, protein and endotoxin while the adsorbed plasmid DNA remained 
on the membrane. Gradient salt concentration for plasmid elution was established by 
programming the mixing ratio between loading and elution buffers employing the Bio-Logic 
LP system. The flow rate was programmed to be 1 ml/min. The elution fractions were 
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collected using BioFrac fraction collector, and subsequently analyzed for plasmid DNA 
recovery. 
5.2.5 Analytical Methods 
5.2.5.1 Quantification of Plasmid DNA 
The concentration of plasmid DNA was quantified using NanoDrop spectrophotometer as 
described in section 3.2.5. The identity of nucleic acids (plasmid DNA, RNA, gDNA) was 
analyzed using agarose gel electrophoresis as described in section 4.2.5.  
5.2.5.2 Quantification of Genomic DNA 
Polymerase chain reaction (PCR) was performed to quantify gDNA in the process stream. 
Oligonucleotide primer pair of 5’-GAA TTC AAA AAT TGT GTC ATC GTC AGT GCG G 
-3’ (sense) and 5’- CTG CAG TTA ATT CAA CCG TTC AAT CAC CAT C -3’(antisense) 
were used to amplify a 1194-bp region of the atoB gene of E. coli. DNA amplification was 
performed in GeneAmp® PCR System 2700 (Applied Biosystem, Life Technologies, 
California, USA) with the following temperature profile: 94°C for 4 min (initial 
denaturation); 20 cycles of 94°C for 1.5 min, 50°C for 45 s and 68°C for 3 min; and 68°C for 
10 min (final extension). Purified E. coli DH5 gDNA (by Qiagen DNeasy® Blood & Tissue 
Kit) was used as the template. Various gDNA standards in the range of 0.05 to 1 g/ml were 
used for calibration of PCR-amplified signals. The number of amplification cycle of 20 was 
experimentally determined to ensure that the DNA amplification was in an exponential stage 
with detectable signals, which were then quantified by Image J. The gDNA concentration of 
each sample was determined based on the calibration data using gDNA standards. 
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5.2.5.3 Protein assay 
Protein concentration was determined by the micro-BCA protein assay (Pierce 
Biotechnology, Rockford, IL, USA) using the microplate method. Absorbance was measured 
at 562 nm with Thermo Labsystems Multiskan Ascent photometric plate reader (Thermo 
Scientific, Wilmington, USA), and the concentration is determined by comparing to the 
standard curve constructed using BSA as the protein standard.  
5.2.5.4 Endotoxin assay 
Endotoxins were quantitatively determined by QCL-1000
®
 endpoint chromatogenic LAL 
assay (Lonza, Walkersville, MD, USA) using microplate method. Absorbance was measured 
at 405 nm with Thermo Labsystems Multiskan Ascent photometric plate reader, and the 
concentration was determined based on the calibration data using endotoxin standards with 
known concentrations.  
5.3 Results 
5.3.1 Calcium Chloride Precipitation 
To determine the operating concentration for the maximal RNA clearance with minimal loss 
of plasmid DNA, a calcium chloride concentration range of 0.5 ~ 3 M was used and the 
results are summarized in Figure 12 and Table 8. Although RNA could be effectively 
removed from the bioprocess stream by increasing calcium chloride concentration, as seen 
with the decreasing band intensity of RNA and increasing ratio between plasmid DNA and 
RNA, the recovery of plasmid DNA was also reduced. In particular, calcium chloride 
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concentrations greater than 1.5 M resulted in a poor plasmid DNA recovery of less than 50%. 
It is generally perceived that a recovery lower than 70% for a single downstream processing 
step is unacceptable [44]. Therefore, calcium chloride concentrations between 1 M and 1.5 M 
were further analyzed for their effectiveness in HMW RNA clearance.  
 
Figure 12 Agarose gel electrophoresis analysis of the supernatant after calcium chloride 
precipitations. Lane 1 is 1 kb DNA ladder, lane 2 is clarified lysate, lane 3 to 7 are cell lysate 




Table 8 Densitometric analysis of samples treated with calcium chloride precipitation in a 
concentration range of 0.5 to 3 M by Image J, and the corresponding plasmid DNA to RNA 












0 M* 29527 889166 0.033 100% 
0.5 M 26279 102680 0.256 89% 
1 M 21065 61314 0.344 71% 
1.5 M 17644 40086 0.440 60% 
2 M 9391 30244 0.311 32% 
3 M 5865 2626 2.233 20% 
* 0 M = clarified lysate 
5.3.2 Isopropanol Precipitation 
The resulting plasmid DNA concentration after calcium chloride precipitation was ~ 40 
µg/ml. Based on the precipitation profiles [65], isopropanol concentration of 60% (vv) was 
used to maximize plasmid DNA recovery.  
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5.3.3 Membrane Chromatography 
The optimal operational ionic strength of the washing buffer was determined by increasing 
the salt concentration of NaCl in a gradient (from 0 M to 0.8 M) to a point where complete 
removal of the adsorbed RNA was achieved. Various fractions corresponding to the elution 
peak were analyzed for nucleic acid content using agarose gel electrophoresis. The results 
suggested that a salt concentration of 0.55 M was sufficient to remove almost all adsorbed 
RNA prior to plasmid elution (Figure 13). Based on the chromatogram (Figure 13 a), a 
washing step of 110 membrane volume was sufficient for RNA removal, which was further 
confirmed by agarose gel electrophoresis of various elution fractions (Figure 13 b). 
Therefore, in the subsequent purification experiments, LMW RNA was removed by washing 
buffer containing 0.55 M NaCl and plasmid DNA was then recovered in a gradient salt 
elution profile starting at 0.56 M.  
a) b)   
Figure 13 a) Chromatogram of membrane chromatography where washing buffer containing 
0.55 M NaCl was applied following 15 minutes of membrane pre-equilibration and 4 minute 
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of sample loading, and b) gel electrophoresis of fractions collected from elution peak in a), 
lane 1 is 1 kb DNA ladder, lane 3 to lane 15 are fractions corresponding to 20 to 31 min on 
chromatogram. 
In a reported purification strategy using only 0.2 M calcium chloride to precipitate 
RNA [71], the incomplete removal of HMW RNA necessitated additional chromatographic 
steps to purify plasmid DNA. Apparently, the concentration of the precipitating agent can 
possibly influence the strategy and even the performance of the subsequent chromatographic 
step(s). To further evaluate the validity of combining the above proposed procedure (i.e. 
calcium chloride precipitation, isopropanol desalting, and anion-exchange membrane 
chromatography), two calcium chloride concentrations lower than 1.5 M (i.e. 1 M and 1.4 M) 
were used in the HMW RNA removing step followed by the other processing steps. 
Purification performance with the two lower calcium chloride concentrations are shown in 
Figure 14 (1 M) and 15 (1.4 M). In the chromatograms for both cases (Figures 14 a and 15 a), 
the first peak corresponded to the elution of RNA during the washing step, whereas the 
second peak corresponded to the elution of plasmid DNA during the gradient elution step 
(Figures 14 b and 15 b). Note the shoulder associated with the second peak (Figure 14 a) and  
the trace amount of HMW RNA detected in the first few plasmid elution fractions for the 
lysate pre-treated with 1 M calcium chloride (Figure 14 b), they all imply that 1 M calcium 
chloride was insufficient for removing total HMW RNA. On the other hand, the eluted 
plasmid DNA was not contaminated by HMW RNA when the lysate was pre-treated with 1.4 
M calcium chloride (Figure 15 b). This seemingly optimal concentration does not appear to 
be plasmid DNA-specific when comparing our results with other studies [7, 24], suggesting 
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1.4 M calcium chloride concentration can be used as a general guideline to precipitate HMW 
RNA from the bioprocess stream.  
 a)    
b)      
Figure 14 a) Chromatogram of membrane chromatography where 1 M calcium chloride was 
used to remove HMW RNA from the cell lysate, and b) gel electrophoresis of elution 
fractions from elution peaks in a), lane 1 and 15 are 1 kb DNA ladder, lane 3 is loading 
lysate, lane 4 to 14 corresponds to first elution peak (I), lane 16 to 29 corresponds to second 




a)    
b)   
Figure 15 a) Chromatogram of membrane chromatography where 1.4 M calcium chloride 
was used to remove HMW RNA from the cell lysate, and b) gel electrophoresis of elution 
fractions from elution peaks, lane 1 and 16 are 1 kb DNA ladder, lane 3 to lane 15 
correspond to first elution peak (I), lane 17 is loading lysate, and lane 19 to 30 correspond to 
second elution peak (II).  
5.3.4 Bioprocess Synthesis   
Figure 16 summarizes the proposed RNase-free bioprocess for the production of 
pharmaceutical-grade plasmid DNA. In particular, three major steps, namely selective 
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precipitation with calcium chloride, isopropanol desalting, and anion-exchange membrane 
chromatography are integrated in a simple and inexpensive manner to purify plasmid DNA 
effectively. As a therapeutic product, the quality of the purified plasmid DNA should meet 
the various criteria for impurities (e.g. gDNA, proteins, and endotoxin) as defined by 
regulatory agencies [3]. In this study, protein and endotoxin were analyzed using standard 
assay kits, whereas gDNA was quantified using PCR with an appropriate cycle number of 20 
since PCR with lower (15) cycles produced weak bands and PCR with higher (30) cycles 
gave saturated bands (data not shown). The results of gDNA quantification are summarized 
in Figure 17 and Table 9. The level of gDNA was greatly reduced after calcium chloride 
precipitation and was undetectable in the bioprocess stream after isopropanol precipitation. 
Table 10 summarizes the performance of all processing steps. Apparently, desalting with 
isopropanol had an additional advantage in removing impurities as there was a 13-fold 
decrease in the protein concentration with the resulting endotoxin level as low as 4.5 EU/µg 
of plasmid DNA after the treatment. The subsequent use of a high-capacity anion-exchange 
membrane further reduced impurity levels of proteins and endotoxin, and the resulting 
endotoxin level is well below  to those specified by the regulatory agencies (<0.01 EU/µg 
plasmid DNA) [38]. In addition to impurity clearance, plasmid DNA recovery is another 
critical factor determining the bioprocess performance. The recoveries of plasmid DNA for 
isopropanol precipitation and anion-exchange membrane chromatography were 83% and 
82%, respectively. In fact, the current recovery for membrane chromatography is higher than 
other reported values [6, 8, 54]. Based on our previous characterization [36], the membrane 
framework becomes completely encased with functionalized hydrogel, which provides a 
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hydrophilic surface for reversible interaction with negatively charged biomolecules. As a 
result, plasmid loss due to irreversible interaction which is often associated with other types 
of membranes was minimized. 
 
Figure 16 Overview of plasmid purification process where purification steps optimized in 




Figure 17 Agarose gel electrophoresis analysis of PCR products of gDNA fragments 
amplified with 20 PCR cycles. Lane 1 is 1 kb DNA ladder; lane 2 to 5 are gDNA standards 
prepared at 0, 0.05, 0.1 and 1 g/ml, respectively; lane 6 and 7 are negative and positive 
controls, respectively; and lane 8 to 11 are samples taken from clarified lysate, post-calcium 















Table 9 Densitometric analysis of gDNA fragments amplified by 20 PCR cycles and the 





























CL= clarified lysate 
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Clarified lysate 118 7364 190 
0.12 
Calcium chloride 105 -* -* 
0.04 
Isopropanol 87 123.9 4.5 
Undetectable 
Membrane 




In the present study, a novel RNase-free downstream bioprocess was developed for the 
purification of pharmaceutical-grade plasmid DNA by optimally integrating calcium chloride 
precipitation, isopropanol precipitation and anion-exchange membrane chromatography for 
their demonstrated ability in HMW RNA removal, desalting and LMW RNA removal, 
respectively.  
The use of calcium chloride at a properly determined concentration (1.4 M) has 
demonstrated the feasibility of complete clearance of HMW RNA with minimum loss of 
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plasmid DNA from the bioprocess stream prior to anion-exchange chromatography. 
Although no explanation has been given to the fact that calcium chloride selectively 
precipitates RNA while leaving plasmid DNA in solution, it is suggested that the single-
stranded nature of RNAs makes it rather vulnerable for the access of divalent cations to  the 
binding sites within their structures as compared to the rigid double-stranded structure of 
supercoiled plasmid DNAs [24, 72], and the precipitation is more effective for RNAs with 
HMW.  This offers a great technical advantage, as the complete separation of HMW RNA 
from plasmid DNA is the major challenge in an RNase-free downstream bioprocess, 
especially if anion-exchange chromatography is used for the subsequent separation of 
biomolecules.  
The high salt level remaining in the cell lysate after selective precipitation using 
calcium chloride interfered with anion-exchange membrane chromatography and resulted in 
immediate breakthrough of plasmid DNA. It is therefore essential to desalt the cell lysate 
prior to membrane chromatography.  Also, plasmid DNA typically comprises less than 1% of 
total cellular mass [17], and consequently it exists in cell lysate in a dilute form. Although the 
majority of gDNA can be easily removed during the initial stages of the purification process, 
a large amount of RNA (representing ~ 80% of total cellular mass) and other impurities 
(proteins and endotoxin) still remain in the cell lysate. Complete separation of these 
impurities in excess amounts from plasmid DNA is particularly difficult. Therefore, 
subsequent operation units capable of desalting, concentrating and impurity reduction are 
needed. In consideration that isopropanol is capable of simultaneously  desalt bioprocess 
stream, concentrate plasmid DNA and partially remove impurities from the bioprocess 
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stream [21], it is employed in this study as a single step to fulfill the requirements of three 
steps. The reduction in processing volume through resuspension of the concentrated nucleic 
acid pellet in buffer solution of a much smaller volume is another technical advantage 
associated with the use of isopropanol precipitation. Most desalting operations [7, 8] are 
rather time-consuming and the product in the bioprocess stream tends to be diluted or even 
degraded during a prolonged desalting process. Also, additional operation units are often 
required to concentrate plasmid DNA and reduce impurity levels [7], which rather adds 
operational complexity to the bioprocess. Therefore, isopropanol precipitation appears to be a 
promising approach by which the above technical concerns can be alleviated. Hence, it was 
explored as a coupling step between calcium chloride precipitation and anion-exchange 
membrane chromatography in this study. 
The selective precipitation with calcium chloride and isopropanol not only 
significantly removed a large fraction of impurities but also concentrated plasmid DNA in an 
appropriate buffer condition for subsequent anion-exchange membrane chromatography. A 
strong anion-exchange membrane was selected as the chromatographic medium based on its 
demonstrated high capacity for plasmid DNA capture and reversibility, as reported in the 
previous study [36]. Using this membrane chromatographic process, the remaining impurities 
(LMW RNA, proteins, endotoxin) were largely eliminated. With a lower overall charge 
density, LMW RNA and other proteinous impurities were often eluted prior to plasmid DNA 
when a gradient elution operation was employed. However, due to similar chemical 
properties of plasmid DNA and RNA, a complete separation of these two types of 
biomolecules has been considered rather difficult [66, 67]. To further improve the 
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purification resolution, the washing buffer was supplemented with a marginally low 
concentration of salt (0.55 M) in order to extensively remove the adsorbed RNA and other 
impurities (e.g. protein) from the anion-exchange membrane without co-elution of plasmid 
DNA during the washing step. Besides being economic in plasmid DNA production, the 
determination of the proper salt concentration used in RNA elution has additional benefit in 
preventing the charged hydrogel from shrinking which would otherwise result in plasmid loss 
due to physical entrapment in the hydrogel matrix.  
The bioprocess developed in this study is simple and yet effective in plasmid yield 
and impurity clearance, which is readily scalable for the production of pharmaceutical-grade 






Alternative Nucleic Acid Precipitant 
The work in this chapter was partially included in “Developing an RNase-free bioprocess 
to produce pharmaceutical-grade plasmid DNA using selective precipitation and 
membrane chromatography”, and was recently submitted to Journal of Separation and 
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Although isopropanol is a widely used nucleic acid precipitant in laboratory-scale 
purification of plasmid DNA, the implementation of this operation on a large scale can result 
in high production cost, which is associated with the capital cost of explosion-proof tank and 
the disposal cost of the waste. Therefore, alternative nucleic acid precipitant is in demand for 
a cost-effective bioprocess on the manufacturing scale. PEG is a promising alternative for its 
biocompatible nature, as it is often used in the formulation of bio-therapeutics. Many studies 
have shown promising results in plasmid DNA isolation from the cell lysate using high 
molecular weight PEG [73, 74]. However, most studies lack the information on the yield of 
plasmid DNA from this operation procedure, which is very important in determining the 
efficiency of the bioprocess as well as decision making for the choice of the operation unit. 
Therefore, the objective of this chapter is to determine the fractionation behavior of 
PEG8000 for nucleic acids as well as its efficiency in resolving plasmid DNA from the rest 
nucleic acid impurities (e.g. gDNA, RNA, other isoforms of plasmid DNA) as compared to 
the previously optimized isopropanol precipitation.  
6.2 Materials and Methods 
6.2.1 Preparation of Cell Lysate 
The clarified lysate was prepared as described in section 5.2.1, and calcium chloride 
precipitation was performed as described in section 5.2.2, where appropriate amount of 4 M 
calcium chloride stock solution was added to the process stream to reach a final 
concentration of 1.4 M.  
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6.2.2 Nucleic Acid Precipitant 
PEG with molecular weight of 8000 was used, and final concentrations of 3%, 6% and 10% 
(w/v) were compared to 60% (v/v) isopropanol for its precipitating efficiency by adding 
appropriate amount of freshly prepared 20% PEG stock solution to cell lysates. After adding 
the precipitant into cell lysate, the mixture was immediately centrifuged at 16,000 × g for 15 
minutes at room temperature, followed by washing with 70% (v/v) ethanol and centrifugation 
at 16,000 × g for 10 minutes at room temperature. The pellet was then resuspended in a 
loading buffer. The same amount of cell lysate from a batch culture was used for all 
precipitation experiments.  Figure 18 summarizes the different precipitating strategies studied 
for the intermediate recovery of plasmid DNA from the bioprocess stream. Plasmid DNA 
recovery and RNA clearance were evaluated by agarose gel electrophoresis and 











Figure 18 Overview of precipitating strategies studied for the intermediate recovery of 
plasmid DNA from the bioprocess stream. 
6.3 Results 
Isopropanol at a final concentration of 60% (v/v) was previously determined to be optimal 
for concentrating plasmid DNA at a concentration of ~ 40 g/ml. Alternatively, PEG 
precipitation at final concentrations of 3%, 6%, and 10% were also explored following 
calcium chloride precipitation. The results are compared in Figure 19 (lane 2 to 5). Due to the 
potential interest for therapeutic applications, only plasmid DNA bands corresponding to the 
supercoiled form were quantified and the results are summarized in Table 11. The plasmid 
DNA band intensity is the highest if isopropanol was used to precipitate plasmid DNA, 
suggesting 60% (v/v) isopropanol is more efficient in precipitating supercoiled plasmid DNA 
at a concentration of ~ 40 g/ml than PEG at all tested concentrations. Among PEG 
precipitations, PEG at 6% precipitated more supercoiled plasmid DNA, followed by 10% and 
3% didn’t precipitate any nucleic acid. The relative recovery efficiency of PEG at 10% and 
6% as compared to 60% (v/v) isopropanol was 39% and 48%, respectively. RNA was 
undetectable in the bioprocess stream after PEG precipitation, whereas a small amount of it 




Figure 19 Agarose gel electrophoresis analysis of the nucleic acid pellets precipitated by 
isopropanol and PEG. Lane 2 to 5 reveal the nucleic acids precipitated with 60% (v/v) 
isopropanol, 10% PEG, 6% PEG and 3% PEG, respectively from the supernatant collected 
after calcium chloride precipitation (1.4 M); and lane 6 to 8 reveals the nucleic acids 
precipitated with PEG concentrations at 10%, 6% and 3%, respectively from the clarified 
lysate. 
Table 11 Densitometric analysis of DNA bands of supercoiled plasmid DNA and the 
corresponding relative recovery efficiency as compared to “calcium chloride and 










CaCl2 + isopropanol 210866 
100 
CaCl2 + 10% PEG 81476 
39 
CaCl2 + 6% PEG 102222 
48 
CaCl2 + 3% PEG 0 
0 
10% PEG 178257 
85 
6% PEG 38681 
18 
3% PEG 0 
0 
 
To investigate whether low plasmid DNA yields were associated with the combined 
usage of calcium chloride and PEG, PEG alone was explored to precipitate plasmid DNA 
directly from clarified lysate and the results are shown in Figure 19 (lane 6 to 8). In addition 
to various isoforms of plasmid DNA, PEG at 10% and 6% also precipitated gDNA and a 
huge amount of RNA. The relative recovery efficiencies as compared to isopropanol are 85% 




While it appears that PEG in combination with calcium chloride was more effective in RNA 
clearance, isopropanol precipitation gave the highest yield of supercoiled plasmid DNA with 
decent RNA clearance. It was suspected that the combined usage of calcium chloride and 
PEG caused major loss of plasmid DNA, therefore PEG precipitation was performed directly 
following primary recovery steps. Apparently, PEG alone failed to separate gDNA and RNA 
from plasmid DNA effectively. The concentration of these impurities in the process stream 
would cause a great burden to subsequent downstream bioprocessing. In addition, the 
plasmid DNA yields based on the use of PEG as the precipitant remained low even without 
the use of calcium chloride, implying isopropanol is a more effective precipitant for 
recovering supercoiled plasmid DNA. The results also suggest that it is crucial to incorporate 
calcium chloride precipitation in the early stage of a  bioprocess for gDNA clearance since 
the separation of gDNA from plasmid DNA can be a major technical challenge in many 





Conclusions and Recommendations 
7.1 Conclusions 
Membrane chromatography is promising to overcome several major challenges associated 
with the large-scale production of plasmid DNAs. In this study, a hydrogel-based strong 
anion-exchange membrane with a high binding capacity was used to demonstrate its potential 
applicability for plasmid DNA purification. While the desired property in membrane 
chromatography is reversible adsorption, rejection and irreversible adsorption of plasmid 
DNAs can be frequently observed. Using the hydrogel membrane, the extent to which these 
undesirable events occurred was found to be dependent on various factors, including the 
membrane porosity, the soaking time, the buffer pH and the size of plasmid DNA tertiary 
structure. Porosity appears to have a major impact on performance. The more porous side of 
the membrane would provide a larger accessible area for plasmid DNA adsorption, thus the 
rejection due to the restrictive membrane pore size and the repulsion by the previously bound 
plasmid DNA could be minimized. In this study it was shown that the porosity can be greatly 
increased by properly pre-treating the hydrogel membrane. With the pre-treatment, pores 
were enlarged, well-structured, and evenly distributed so that the binding capacity for 
plasmid DNAs could be substantially enhanced. In addition, the hydrophilic 
supermacroporous hydrogel could completely encase the membrane support and the 
irreversible adsorption of plasmid DNAs to the hydrophobic membrane support was reduced. 
The approach greatly reduced plasmid DNA loss associated with the irreversible adsorption 
to the membrane support that is commonly observed for many commercially available anion-
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exchange membranes. The tertiary structure of plasmid DNA, as determined by the degree of 
supercoiling also had an effect. While the size effect on the adsorption was negated by the 
enlargement of pores by proper pre-treatment, but the size effect persisted for desorption. In 
general, a higher desorption was observed for small plasmid DNAs. Buffer pH had a more 
pronounced impact on desorption behaviour of plasmid DNA than other factors because it 
could potentially affect the size of the tertiary structure of plasmid DNA and/or surface 
charge density. Through a careful selection of the operating pH, the recovery can be further 
improved. The optimal pH appeared to be plasmid DNA-dependent. The high convective 
flow through the supermacroporous structure of the hydrogel membrane, as compared to the 
diffusive transport through the interior of the resin beads, would be an important processing 
benefit.  
The presently developed RNase-free bioprocess based on the combined use of 
selective precipitations and anion-exchange membrane chromatography. IT is simple, easy to 
operate, economical, and effective in producing pharmaceutical-grade plasmid DNA as it 
involves far less purification steps in comparison to other existing technologies [7, 8, 18]. 
The optimal determination of the operating condition for calcium chloride precipitation 
serves as an important prerequisite not only to remove a significant amount of gDNA and 
RNA impurities in the bioprocess stream but also to enhance the performance of subsequent 
purification steps. The implementation of isopropanol precipitation offers several technical 
advantages, including desalting the bioprocess stream, concentrating plasmid DNA, and 
further removing various impurities in the bioprocess stream. The present study also 
demonstrates the technical feasibility of applying anion-exchange chromatography with 
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single-use high-capacity hydrogel membranes for effective purification of plasmid DNA, 
which saves time of labour intensive procedures (i.e. washing, cleaning, and regenerating) 
associated with the conventional resin-based chromatography, and at the same time provides 
much better membrane performance in binding capacity and biomass flow. For the 
chromatographic operation, the optimal determination of operating condition for the washing 
step ensures a complete RNA separation from plasmid DNA, which is a major technical 
concern for most RNase-free bioprocesses for the production of plasmid DNA. These 
purification steps were optimally integrated to ensure that the final product of plasmid DNA 
meets the regulatory standards for therapeutic applications.  
7.2 Recommendations 
Given the successful demonstration in the proposed bioprocess development, the plasmid 
product contained both supercoiled and open circular isoforms. The biological activity of 
plasmid DNA is often associated with its topological structure [75, 76] and the supercoiled 
isoform is more suitable for therapeutic applications [77]. It is believed that, by careful 
implementation of bioprocessing steps with optimal operating conditions, supercoiling can be 
enhanced. As such, following is recommended for future work to improve plasmid DNA 
purity. 
1. A gentle and yet effective lysis technique is required to release the highest 
possible amount of supercoiled plasmid DNA. As it is the first step in plasmid 
DNA recovery from the host cells, the efficiency is critical for the overall yield.  
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2. Compare centrifugation with microfiltration for biomass removal, as it is 
proposed that microfiltration is gentle on the shear-stress sensitive plasmid DNA 
[18].  
3. Include an additional chromatography following anion-exchange membrane 
chromatography, such as SEC or HIC, to selectively isolate supercoiled plasmid 
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